CD8A and neoplasm: As a result, PD‐1 can be used to identify various types of specific anti‐tumor CD8+ T cells and develop personalized medicine‐based treatment approaches such as NRT immunotherapy.[80] It has been demonstrated that microwell culturing can prevent the overgrowth of non‐reactive T cells.